Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study. (Q42687704)

From Wikidata

Jump to navigation Jump to search

scientific article published on September 2017

Language	Label	Description	Also known as
English	Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study.	scientific article published on September 2017

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870611%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870611%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

1 reference

based on heuristic

inferred from title

malignant pleural mesothelioma

1 reference

based on heuristic

inferred from title

recurrent malignant pleural mesothelioma

1 reference

based on heuristic

inferred from title

Michael J. Boyer

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870611%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870611%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870611%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

object named as

Stephen Clarke

6

1 reference

ORCID Public Data File 2021

author name string

Nico van Zandwijk

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870611%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Nick Pavlakis

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870611%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Steven C Kao

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870611%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Anthony Linton

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870611%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Yennie Huynh

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870611%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Agata Chrzanowska

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870611%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Dale L Bailey

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870611%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Wendy A Cooper

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870611%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Leonard Kritharides

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870611%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Lloyd Ridley

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870611%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Scott T Pattison

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870611%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Jennifer MacDiarmid

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870611%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Himanshu Brahmbhatt

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870611%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

publication date

1 September 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870611%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Lancet Oncology Commission

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870611%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870611%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

1386-1396

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870611%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870611%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

A catalogue of treatment and technologies for malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

MicroRNAs: target recognition and regulatory functions

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Diversifying microRNA sequence and function

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Most mammalian mRNAs are conserved targets of microRNAs

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Minicells: versatile vectors for targeted drug or si/shRNA cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeted epidermal growth factor receptor therapy in malignant pleural mesothelioma: where do we stand?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Malignant pleural mesothelioma and epidermal growth factor receptor (EGF-R). Relationship of EGF-R with histology and survival using fixed paraffin embedded tissue and the F4, monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Modified RECIST criteria for assessment of response in malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A First-Time-In-Human Phase I Clinical Trial of Bispecific Antibody-Targeted, Paclitaxel-Packaged Bacterial Minicells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Towards new methods for the determination of dose limiting toxicities and the assessment of the recommended dose for further studies of molecularly targeted agents--dose-Limiting Toxicity and Toxicity Assessment Recommendation Group for Early Trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of expression of programmed cell death 1 ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Design considerations for nanotherapeutics in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeted Doxorubicin Delivery to Brain Tumors via Minicells: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Haemolysis during sample preparation alters microRNA content of plasma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

First in human nanotechnology doxorubicin delivery system to target epidermal growth factor receptors in recurrent glioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical outcome of critically ill patients with thrombocytopenia and hypophosphatemia in the early stage of sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between hypophosphatemia and cardiac arrhythmias in the early stages of sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Structural changes of the heart during severe sepsis or septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Overcoming cellular barriers for RNA therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

RNA Interference-Induced Innate Immunity, Off-Target Effect, or Immune Adjuvant?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of intrapleural recombinant gamma-interferon in malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunotherapy for malignant mesothelioma: Reality check

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Second line therapy in malignant pleural mesothelioma: A systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of phase 1 trials in malignant pleural mesothelioma: description of a series of patients at a single institution

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A Significant Metabolic and Radiological Response after a Novel Targeted MicroRNA-based Treatment Approach in Malignant Pleural Mesothelioma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1-Deficient Malignant Pleural Mesothelioma: A Randomized Clinical Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2817%2930621-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(17)30621-6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870611%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

release_kyx6nlnwzbftfngqpzfdpmquye

1 reference

https://api.fatcat.wiki/v0/release/kyx6nlnwzbftfngqpzfdpmquye

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28870611%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42687704&oldid=1843347036"